# Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)

> **NCT05216133** · — · ENROLLING_BY_INVITATION · sponsor: **NYU Langone Health** · enrollment: 200 (estimated)

## Conditions studied

- Airway Disease
- Barrett Esophagus
- Gastroesophageal Reflux Disease

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05216133
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2023-03-22
- **Primary completion:** 2027-06
- **Final completion:** 2027-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05216133

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05216133, "Biomarkers of Airway Disease, Barrett's and Underdiagnosed Reflux Noninvasively (BADBURN)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05216133. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*